Presentation is loading. Please wait.

Presentation is loading. Please wait.

Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the.

Published byGyles Lewis Modified over 6 years ago

Similar presentations

Presentation on theme: "Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the."— Presentation transcript:

1 Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. (+) favours TAVR; (–) favours SAVR. Based on the recommendations formulated in the 2017 ESC/EACTS guidelines on the management of valvular heart disease. EACTS, European Association of CardioThoracic Surgery; ESC, European Society of Cardiology, SAVR, surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement. Tasalak Thonghong et al. Open Heart 2018;5:e000753 ©2018 by British Cardiovascular Society

Download ppt "Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the."

Similar presentations

Secondary Prevention Following Coronary Artery Bypass Grafting: are we Compliant with the Guidelines? V. Joshi, B. Bridgewater University Hospital of South.

Secondary Prevention Following Coronary Artery Bypass Grafting: are we Compliant with the Guidelines? V. Joshi, B. Bridgewater University Hospital of South.
PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.

PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.
© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5:580-588 A comparison of patient characteristics and 30-day mortality outcomes after.

© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.
Figure 1 Causes of bioprosthetic valve dysfunction.

Figure 1 Causes of bioprosthetic valve dysfunction.
Anita W. Asgar MD, FRCPC, FACC Montreal Heart Institute

Anita W. Asgar MD, FRCPC, FACC Montreal Heart Institute
Relation of aortic regurgitation to all-cause mortality in the transcatheter aortic valve replacement (TAVR) as-treated population of the Placement of.

Relation of aortic regurgitation to all-cause mortality in the transcatheter aortic valve replacement (TAVR) as-treated population of the Placement of.
The Aortic Valve Patient Learning Objectives

The Aortic Valve Patient Learning Objectives
Are we ready for expanding TAVI indications to moderate and low risk

Are we ready for expanding TAVI indications to moderate and low risk
From: Functional Status and Quality of Life After Transcatheter Aortic Valve ReplacementA Systematic Review Ann Intern Med. 2014;160(4):243-254. doi:10.7326/M13-1316.

From: Functional Status and Quality of Life After Transcatheter Aortic Valve ReplacementA Systematic Review Ann Intern Med. 2014;160(4): doi: /M
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity- Matched Comparison  Dale M. Kobrin, BA, Fenton H. McCarthy, MD,

Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity- Matched Comparison  Dale M. Kobrin, BA, Fenton H. McCarthy, MD,
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.

Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.

Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
An example adjunctive CT imaging in the management of aortic valve replacement dysfunction. An example adjunctive CT imaging in the management of aortic.

An example adjunctive CT imaging in the management of aortic valve replacement dysfunction. An example adjunctive CT imaging in the management of aortic.
Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.

Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.
Update in Cardiac and Thoracic Surgery

Update in Cardiac and Thoracic Surgery
Ao, aorta; AR, aortic regurgitation; CFD, color-flow Doppler; LV, left ventricle; LV EDP, left ventricular end-diastolic pressure; PW, pulse-wave; SBP,

Ao, aorta; AR, aortic regurgitation; CFD, color-flow Doppler; LV, left ventricle; LV EDP, left ventricular end-diastolic pressure; PW, pulse-wave; SBP,
Management of Patients With Aortic Valve Stenosis

Management of Patients With Aortic Valve Stenosis
Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting  John V. Conte, MD, Thomas G. Gleason, MD, Jon.

Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting  John V. Conte, MD, Thomas G. Gleason, MD, Jon.

Similar presentations

Ads by Google